Lates News

In the first quarter, Medtronic reported an adjusted loss of $0.03 per share, while analysts had expected a loss of $0.10 per share. Net sales for the first quarter were $8.266 billion, exceeding analysts' expectations of $7.886 billion. The company has maintained its target of repurchasing $6 billion worth of stock by 2025.